Myocardial Contrast Echocardiography Evaluation of Tirofiban for the Myocardial Reperfusion of NSTEMI Patients Underwent PCI Treatment
10.13241/j.cnki.pmb.2017.24.032
- VernacularTitle:替罗非班对NSTEMI患者PCI术后心肌再灌注影响的心肌声学造影评价
- Author:
Zhen WANG
;
Bo ZHENG
;
Zongqing LI
;
Fangxia ZHANG
;
Huipu XU
- Keywords:
Non-ST segmant elevated myocardial infarction;
Percutaneous coronary intervention;
Myocardial reperfusion;
Tirofiban
- From:
Progress in Modern Biomedicine
2017;17(24):4731-4734
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the improvement effect of tirofiban on the myocardial reperfusion of non-ST segmant elevated myocardial infarction (NSTEMI) patients underwent percutaneous coronary intervention (PCI) treatment.Methods:78 NSTEMI patients underwent PCI in our hospital from April 2012 to April 2015 were selected and divided into the observation group (n=38) and the control group (n=40) according to different drugs.Patients in the control group were given asprin,clopidogrel and heparin,while patients in the observation group were additionally given tirofiban.Then the myocardial contrast echocardiography (MCE) was taken to evluate the myocardial reperfusion.Results:No statistical difference was found in the levels of A,β,A β,CK-MB and cTnⅠ before PCI between 2 groups.The levels of β,A β of observation group were obviously higher,CK-MB and cTnⅠ were obviously lower than those of the control group(P＜0.05).The MACE rate of observation group was 2.63％,which was 5.00％ in the control group,no significant difference was between two groups (P＞0.05).Conclusion:Tirofiban could obviously improve the myocardial reperfusion of NSTEMI patients underwent PCI with high safety.
